MedPath

Ampicillin

Ampicillin for Injection, USP (For Intramuscular or Intravenous Injection)

Approved
Approval ID

e11cdf7e-3e2a-0eb3-e053-2995a90ab629

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 2, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

AMPICILLIN SODIUM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7286
Application NumberANDA090583
Product Classification
M
Marketing Category
C73584
G
Generic Name
AMPICILLIN SODIUM
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 2, 2023
FDA Product Classification

INGREDIENTS (1)

AMPICILLIN SODIUMActive
Quantity: 1 g in 1 1
Code: JFN36L5S8K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ampicillin - FDA Drug Approval Details